Transitional cell carcinoma in dogs: Increased life expectancy

Authors

  • Sabrini Schefer Universidade Federal de Santa Maria
  • Paula Cristina Basso Universidade Federal de Santa Maria
  • Daniel Curvello de Mendonça Müller Universidade Federal de Santa Maria

DOI:

https://doi.org/10.31533/pubvet.v14n7a618.1-4

Keywords:

Neoplasm, chemotherapy, survival

Abstract

Transitional cell carcinoma is rare in dogs, with an unfavorable prognosis and life expectancy close to one and a half years. This article aims to describe the diagnosis and therapeutic management in case of transitional cell carcinoma in a twelve-year-old and eight-month-old dog. Clinical signs included polururia and strangury, with no changes in laboratory tests. The definitive diagnosis was made by biopsy throud cystoscopy, which resulted from material characterized by neoplastic proliferation composed of epithelial cells originating from the transition epithelium. After a chemotherapy protocol with carboplatin associated with piroxicam, there was a survival of 1170 days for this patient, with quality of life.

Published

2020-09-04

Issue

Section

Medicina veterinária

How to Cite

Transitional cell carcinoma in dogs: Increased life expectancy. (2020). Pubvet, 14(07). https://doi.org/10.31533/pubvet.v14n7a618.1-4

Most read articles by the same author(s)